beta, beta-dimethylacrylshikonin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zeng, Z; Zhu, BH | 1 |
| Arha, D; Mishra, A; Narender, T; Pandeti, S; Reddy, SS; Srivastava, AK; Tamrakar, AK | 1 |
2 other study(ies) available for beta, beta-dimethylacrylshikonin and Alloxan Diabetes
| Article | Year |
|---|---|
Arnebin-1 promotes the angiogenesis of human umbilical vein endothelial cells and accelerates the wound healing process in diabetic rats.
Topics: Alloxan; Animals; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Male; Naphthoquinones; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Wound Healing | 2014 |
Glucose uptake stimulatory potential and antidiabetic activity of the Arnebin-1 from Arnabia nobelis.
Topics: Animals; Biological Transport; Boraginaceae; Cell Line; Diabetes Mellitus, Experimental; Glucose; Glucose Transport Proteins, Facilitative; Hypoglycemic Agents; Mice; Muscle Fibers, Skeletal; Naphthoquinones; Phosphatidylinositol 3-Kinases; Rats; Signal Transduction | 2016 |